Prediction of sinus rhythm maintenance following DC-cardioversion of persistent atrial fibrillation – the role of atrial cycle length by Meurling, Carl J et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Cardiovascular Disorders
Open Access Research article
Prediction of sinus rhythm maintenance following 
DC-cardioversion of persistent atrial fibrillation – the role of atrial 
cycle length
Carl J Meurling*1, Anders Roijer1, Johan EP Waktare2, Fredrik Holmqvist1, 
Carl J Lindholm1, Max P Ingemansson1, Jonas Carlson1, Martin Stridh3, 
Leif Sörnmo3 and S Bertil Olsson1
Address: 1Department of Cardiology, Lund University Hospital, SE-221 85 Lund, Sweden, 2The Cardiothoracic Centre, Liverpool, UK and 
3Department of Applied Electronics, Lund Institute of Technology, Lund, Sweden
Email: Carl J Meurling* - carl.meurling@skane.se; Anders Roijer - anders.roijer@skane.se; Johan EP Waktare - johan@waktare.net; 
Fredrik Holmqvist - fredrik.holmqvist@med.lu.se; Carl J Lindholm - Carl-Johan.Lindholm@kard.lu.se; 
Max P Ingemansson - max.ingemansson@skane.se; Jonas Carlson - jonas.carlson@med.lu.se; Martin Stridh - msh@es.lth.se; 
Leif Sörnmo - Leif.Sornmo@es.lth.se; S Bertil Olsson - bertil.olsson@med.lu.se
* Corresponding author    
Abstract
Background:  Atrial electrical remodeling has been shown to influence the outcome the outcome
following cardioversion of atrial fibrillation (AF) in experimental studies.
The aim of the present study was to find out whether a non-invasively measured atrial fibrillatory cycle
length, alone or in combination with other non-invasive parameters, could predict sinus rhythm
maintenance after cardioversion of AF.
Methods:  Dominant atrial cycle length (DACL), a previously validated non-invasive index of atrial
refractoriness, was measured from lead V1 and a unipolar oesophageal lead prior to cardioversion in 37
patients with persistent AF undergoing their first cardioversion.
Results: 32 patients were successfully cardioverted to sinus rhythm. The mean DACL in the 22 patients
who suffered recurrence of AF within 6 weeks was 152 ± 15 ms (V1) and 147 ± 14 ms (oesophagus)
compared to 155 ± 17 ms (V1) and 151 ± 18 ms (oesophagus) in those maintaining sinus rhythm (NS). Left
atrial diameter was 48 ± 4 mm and 44 ± 7 mm respectively (NS). The optimal parameter predicting
maintenance of sinus rhythm after 6 weeks appeared to be the ratio of the lowest dominant atrial cycle
length (oesophageal lead or V1) to left atrial diameter. This ratio was significantly higher in patients
remaining in sinus rhythm (3.4 ± 0.6 vs. 3.1 ± 0.4 ms/mm respectively, p = 0.04).
Conclusion: In this study neither an index of atrial refractory period nor left atrial diameter alone were
predictors of AF recurrence within the 6 weeks of follow-up. The ratio of the two (combining
electrophysiological and anatomical measurements) only slightly improve the identification of patients at
high risk of recurrence of persistent AF. Consequently, other ways to asses electrical remodeling and / or
other variables besides electrical remodeling are involved in determining the outcome following
cardioversion.
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Background
Once atrial fibrillation (AF) has been present for more
than a few days, the optimal method for restoring sinus
rhythm is DC-cardioversion[1,2]. Unfortunately, only
about 25% of the patients remain in sinus rhythm at one
year post-cardioversion, with the proportion rising to
approximately half of patients if pharmacoprophylaxis is
employed [3-5]. Most patients who relapse to AF the first
year do so within a few weeks of cardioversion[6,7].
A number of clinical and demographic features have been
suggested to be helpful in predicting successful cardiover-
sion and long term maintenance of sinus rhythm post-car-
dioversion[1-5,8]. Reports investigating the effects of
prolonged tachycardia on atrial electrophysiology have
found that high frequency depolarisation in the atria lead
to electrophysiological changes such as shortening of the
atrial refractory period, which promote self-perpetuation
of the arrhythmia [9-11]. This phenomenon, termed atrial
electrical remodeling, is at least partly reversible following
arrhythmia termination in animal models[9,12,13] but
data in man is conflicting[14,15]. Furthermore, inducibil-
ity of AF is high during the period of recovery and corre-
lates to the length of the refractory period[9,10,12,15],
which may explain the high propensity of AF to relapse
early post-cardioversion. The role of the length of atrial
refractory period in patients with persistent AF (i.e.
already established electrical remodeling) in predicting
outcome of DC-cardioversion is unclear. A recent study
addressed the question with positive results, but its com-
plex patient selection makes it difficult to infer the results
to clinical practice[16].
Since both electrophysiological and morphological fac-
tors may influence the outcome of cardioversion, the aim
of this study was to evaluate whether an index of atrial
refractoriness during AF, a probable marker of the degree
of fibrillation-induced remodeling, alone or in combina-
tion with anatomical atrial parameters could predict out-
come of elective DC-cardioversion of persistent AF.
Methods
Study population
Patients referred to our department with persistent AF
undergoing their first elective DC conversion were
screened for possible recruitment to the study. Exclusion
criteria were overt heart failure and coronary heart disease,
hyperthyroidism or ongoing treatment with Vaughan Wil-
liams class I or III anti-arrhythmic drugs.
All patients gave informed consent. The study complies
with the Declaration of Helsinki and was approved by the
local Ethics Committee, Faculty of Medicine, Lund Uni-
versity, Lund, Sweden.
Frequency analysis of fibrillatory ECG
Frequency analysis of fibrillatory ECG (FAF-ECG) is a val-
idated, non-invasive method for estimating atrial fibrilla-
tory rate by computerized processing of a surface recorded
ECG signal [17-19]. It involves the recording of high reso-
lution ECG, computerized identification, templating and
removal of ventricular components of the ECG to leave a
pure atrial recording, and finally frequency domain based
analysis of this atrial recording.
A standard 12-lead ECG was acquired using a custom
made optically isolated PC card (Siemens Elema AB,
Solna, Sweden). The electrode position configuration is
conventional with the exception that the C6 chest lead is
connected to an oesophageal electrode (Medtronic
6992A, Medtronic Inc., Minneapolis, Min. USA) to give a
unipolar oesophageal electrogram. The digital signal (1
kHz sampling, 16 bit analogue-to-digital conversion, 0.6
µV resolution) was transferred to a personal computer,
where the data was written to a file for subsequent off-line
processing.
Cancellation of the QRST is performed and the residual
signal subjected to frequency domain analysis using fast
Fourier transformation. The frequency peak in the 3 to 12
Hz band with the highest amplitude is automatically cho-
sen by the analytical software. This value is converted to a
cycle length termed the dominant atrial cycle length
Table 1: Clinical characteristics
AGE < 65 yrs 65–74 yrs ≥ 75 yrs
11 19 7
WEIGTH < 75 kg 75–89 kg ≥ 90 kg
61 9 1 1
AF-duration < 4 months 4–12 months ≥ 12 months
13 20 4
EF < 40 % 40–54 % ≥ 55 %
56 2 6
LA-diameter < 40 mm 40–49 mm ≥ 50 mm
32 2 1 2
Summary of the clinical and echocardiographic characteristics of the 37 patients recruited to the study. Weight data is missing for one patient.BMC Cardiovascular Disorders 2006, 6:11 http://www.biomedcentral.com/1471-2261/6/11
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(DACL), which has been shown to be an index of atrial
refractoriness [20-22]. In this study, lead V1 and the uni-
polar oesophageal lead were analysed. Previous studies
have shown that the V1 lead correlates well with the spa-
tial mean of intracardiac recordings from the right atrial
free wall[23]. The oesophageal lead has more extensive
influences, correlating to posterior left and right atria as
well as the interatrial septal intracardiac signals[23]. Since
there are some evidence that the left atrium is more
involved in the initiation mechanism of AF[24], there are
some theoretical advantages using an oesophageal lead.
Cardioversion
FAF-ECG was acquired after 15 minutes supine rest, 30–
60 minutes before elective DC cardioversion. DC-conver-
sion was performed with one electrode paddle in a right
parasternal position and the other at the cardiac apex (lat-
eral thorax in the mid-axillary line), with initial shock
energy of 200 J. If unsuccessful, another shock of 200 J,
and finally a shock of 360 J was given. Successful DC car-
dioversion was defined as electrocardiographic documen-
tation of abolition of AF with at least two sinus beats seen.
Follow-up
All patients in sinus rhythm underwent 12-lead ECG prior
to hospital discharge (4 hours), and at 1, 3 and 6 weeks
post cardioversion. Cardioactive medications were left
unchanged for the duration of the study.
Statistics
Values are expressed as mean values ± standard deviation,
unless otherwise specified. Duration of sinus rhythm is
expressed as median and range. The Mann-Whitney U test
and Fisher's exact test was used to determine whether
there was any significant difference between the groups.
Spearman's rank correlation coefficient was calculated to
determine whether there was any correlation between
DACL and left atrial diameter. A p < 0.05 was considered
statistically significant. Statistical analyses were performed
using StatView for Windows, version 4.5 (Abacus Con-
cepts, Inc., Berkeley, CA, USA).
Illustration of the FAF-ECG method Figure 1
Illustration of the FAF-ECG method. Illustration of the 
process by which DACL is calculated, and explanation of the 
additional parameters which were tested in this study. (a) 
The digital ECG is analysed and the QRST identified and tem-
plated. (b) The template is then subtracted from the raw 
ECG to give a signal representing the atrial fibrillation alone. 
(c) The frequency at which the peak is seen is expressed as a 
cycle length to give the DACL. The DACL recorded from 
lead V1 (black line) is longer (i.e. fibrillation frequency lower) 
than that in oesophageal lead (grey line) in this patient, which 
is the most common finding.
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Sinus rhythm maintenance following cardioversion Figure 2
Sinus rhythm maintenance following cardioversion. 
An illustration of sinus rhythm maintenance in this study. 
Note that the abscissa is a non-linear scale due to the availa-
ble follow-up data.
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Results
Study population
The study population compromised 37 outpatients (27
male). Relevant co-morbidity included hypertension (8
patients), moderate valvular heart disease (1 patient each
with aortic stenosis and mitral regurgitation) and chronic
airflow obstruction (4 patients). Cardioactive pharmaco-
therapy included β-blockers (4 patients), calcium channel
antagonists (3 patients), ACE-inhibitors (3 patients) and
digoxin (14 patients). Mean age was 69 ± 6 years (range
58 to 84 years) and the median AF duration was 5 months
(range 1 to 21 months). Echocardiographic mean left
atrial diameter (anterior-posterior dimension in the par-
asternal view) was 47 ± 5 mm (range 35 to 57 mm), and
the mean left ventricular ejection fraction was 51 ± 9 %
(range 20 to = 55%). The clinical characteristics of the
subjects are summarised in Table 1.
Cardioversion restored sinus rhythm in 32 of the 37
patients in the study, but at 6 weeks only 10 patients
remained in sinus rhythm (Figure 2). Analysable fre-
quency spectra ("FAF-ECG's") were obtained in 34
patients (one of these only had a satisfactory spectrum in
V1, leaving 33 patients for analysis of oesophageal lead
data).
Of the other patient characteristics studied (i.e. gender,
age, atrial fibrillation duration, and presence of underly-
ing heart disease) and echocardiographic parameters
measured (left atrial diameter and ejection fraction), none
showed a definite relationship with conversion rate. There
was a trend for those with a primary failure of cardiover-
sion to be heavier (98 ± 30 kg vs. 85 ± 12 kg, NS) and for
their BMI to be higher (31 ± 9 vs. 28 ± 4, NS).
Patients who remained in sinus rhythm tended to have
shorter atrial fibrillation duration, a smaller left atrial
diameter (Figure 3a) and a higher ejection fraction, but
none of these variables alone reached statistical signifi-
cance and other features such as age and body weight did
not appear to influence atrial fibrillation recurrence (table
2).
Prediction of successful cardioversion and AF recurrence 
by DACL
Patients successfully restored to sinus rhythm had a mean
DACL in lead V1 of 153 ± 15 ms v 158 ± 21 ms in the
patients who had a primary failure of cardioversion (NS).
Comparable data for the oesophageal lead was 148 ± 15
ms vs. 151 ± 13 ms (NS).
Among patients who had been cardioverted, DACL was
non-significantly longer in those who remained in sinus
rhythm at 6 weeks (155 ± 17 ms in V1, 151 ± 18 ms in the
oesophageal lead) than those who had relapsed to AF by
this point (152 ± 15 ms in V1, 147 ± 14 ms in the
oesophageal lead, p = NS for both, Figure 3b). Utilising
the shortest DACL value from either lead did not improve
discriminatory power (NS, table 2). DACL did not corre-
late with left atrial diameter, with a Spearman R = 0.25 for
DACL from lead V1 (NS) and R = -0.04 from the oesopha-
geal lead (NS).
Combined electrophysiological and anatomical 
parameters to predict AF recurrence
The ratio of oesophageal lead DACL to left atrial diameter
was higher in patients who remained in sinus rhythm at 6
weeks, 3.5 ± 0.6 ms/mm, than in those who reverted to
AF, who had a mean ratio of 3.1 ± 0.4 ms/mm with bor-
derline significance (p = 0.05). A similar difference was
seen when calculated based upon lead V1, again with bor-
derline significance (3.6 ± 0.4 vs. 3.2 ± 0.5 ms/mm respec-
tively, p = 0.05). The optimal parameter appeared to be
the ratio of the lowest DACL (oesophageal lead or V1) to
left atrial diameter, which was significantly higher in
patients remaining in sinus rhythm (3.4 ± 0.6 vs. 3.1 ± 0.4
ms/mm respectively, p = 0.04, Figure 3c and Figure 4).
Discussion
Electrical and structural atrial remodeling – effect on AF 
recurrence
During AF alterations of the electrophysiological proper-
ties of the atria occur, evidenced by progressive shortening
in the refractory periods and loss of normal rate adapta-
tion response[9,25]. Previous studies have shown that a
critical number of existing wavelets is essential for AF to
be sustained. Since the length of the wavelet is the product
of myocardial conduction velocity and refractory period,
a decrease in either conduction velocity or a decrease of
the refractory period will lead to an increase in the maxi-
mum number of wavelets that can be accommodated in a
constant area. Similarly, a larger number of circulating
wavelets can exist on the surface of larger atria[26,27].
During the recovery period, following conversion to SR,
the atria have a heightened predilection of AF recur-
rence[9,12,25]. Atria exhibiting a short wavelength have
been shown to be more vulnerable to arrhythmia induc-
tion[24]. This is in agreement with observations that the
ease of initiation and probability of maintenance of AF are
related to the fibrillatory cycle length[27,28]. The time-
course of restoration of normal atrial electrophysiology is
poorly understood, but appears to be partially dependent
on the duration of the arrhythmia before cardioversion.
Studies suggest that atrial effective refractory period
reverts to normal within three days of cardioversion of
long-standing AF[14]. It has been postulated that electri-
cal remodeling is partially due to intracellular calcium
overload since verapamil attenuates the proc-
ess[11,12,15]. Pre-treatment with verapamil may
reduce[6,7,29] and that digoxin[30] delays reversal ofBMC Cardiovascular Disorders 2006, 6:11 http://www.biomedcentral.com/1471-2261/6/11
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electrical remodeling, which may have an impact on the
incidence of early AF recurrence. Moreover, AF also leads
to progressive mechanical dysfunction[31], seen as post
cardioversion atrial stunning. A recent study has shown a
relationship between transmitral peak A wave velocity
and relapse into AF[32]. Left atrial dilation in patients
with AF may be caused by underlying cardiovascular and
valvular disease, but progressive dilatation is also a conse-
quence of the arrhythmia itself[33,34]. Conversely, left
atrial diameter decreases after successful cardioversion to
sinus rhythm[35]. Atrial dilation increases the predilec-
tion to AF, and to its post-cardioversion recurrence, prob-
ably by impeding intra-atrial conduction and by
increasing the atrial area in which multiple wavelet re-
entry can occur.
Prediction of successful restoration of sinus rhythm
Sinus rhythm was restored in 32 of 37 patients. Patients
who failed cardioversion tended to have larger left atria
and, paradoxically, a longer atrial fibrillatory cycle length.
Neither parameter however, nor the combination of the
two, proved an important predictor of outcome. Success-
ful cardioversion is dependent upon cardioversion tech-
nique and transthoracic impedance, which is influenced
by body size, obesity and the presence of pulmonary dis-
ease[36]. Some data suggest left atrial enlargement
decreases the probability of cardioversion[8] while others
do not[37]. Thus although there may be a contribution of
electrical and structural remodeling to cardioversion rates,
the major determinants are likely to be procedural.
Prediction of maintaining sinus rhythm post-cardioversion
Previous studies have shown that type of underlying dis-
ease, AF duration and the patients functional class are pre-
dictors of maintaining sinus rhythm after
cardioversion[1,4,5,38]. Radiographic determined heart
size[4,5] and increased of the mitral inflow Doppler A-
wave amplitude 4 to 24 hours post cardioversion also pre-
dict AF recurrence[38]. Some studies have found that
increased left atrial diameter is a predictor of AF
relapse[8,39], but data is conflicting[1]. Our study found
a trend for atrial diameter to be greater in patients who
ultimately relapsed back into AF, but this failed to reach
statistical significance. Overall these clinical and echocar-
diographic parameters have low predictive value and a
more refined tool is needed.
It is logical that the degree of electrical remodeling will
influence the probability of AF recurrence. However, esti-
mation of the degree of remodeling is uncertain because
the patients do not have the same initial and final refrac-
tory period during AF. Animal studies suggest electrical
remodeling develops quickly[11], following a logarithmic
curve of rapid initial decline in action potential duration
and gradual late decay[9,11], but few data are available
regarding the time-course in humans. In addition, the
absolute value of the atrial effective refractory period may
have an independent influence on AF recurrence as a short
refractory period allows the coexistence of more re-entrant
wavelets and hence provide a superior substrate for re-ini-
tiation. Thus an index of atrial refractory period duration,
such DACL, may provide a measure of AF re-inducibility
and of the degree of atrial remodeling which is relatively
independent of structural and clinical parameters.
The present study found a trend for DACL to be shorter in
patients who subsequently relapsed into AF, but this did
not prove to be independently predictive. Since all our
patients had been in AF for more than a month it is likely
that all were fully electrically remodelled, however to dif-
ferent degrees according to the DACL-values. Measure-
Sinus rhythm maintenance following cardioversion Figure 3
Sinus rhythm maintenance following cardioversion. 
(a) DACL, and (b) the ratio of DACL to left atrial diameter 
according to outcome. AF = patients in atrial fibrillation at 6 
weeks after an initially successful cardioversion; SR = those in 
sinus rhythm; DACL = dominating atrial cycle length; LA = 
left atrial diameter; V1 = lead V1; Oes = unipolar oesopha-
geal lead; Minimum = minimum DACL of the values in V1 and 
oesophagus. Solid circles represent the mean and error bars 
are ± 1SD.
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ment of DACL may therefore have a more important
independent role in predicting arrhythmia recurrence in
patients undergoing cardioversion of shorter arrhythmia
duration (i.e. AF present for between 1 day and 1 month).
In a recent publication[16], the same method as in the
present study used to explore the predictive capabilities of
an index of atrial refractivity. In the study a significant dif-
ference in atrial fibrillatory rate (equals [cycle length]-1)
between patients maintaining sinus rhythm for two weeks
and those with early AF relapse was demonstrated. The
patient characteristics are strikingly similar to the material
in the present study with two key exceptions. Firstly, and
perhaps most importantly, all patients in the study by
Bollmann et al were started on class I or III anti-arrhyth-
mic drug treatment after study inclusion. I.e. patients were
investigated without anti-arrhythmic drugs, but during
follow-up they were all on anti-arrhythmic drugs, making
the interpretation of the finding less obvious. Secondly, in
the study by Bollmann et al the mean duration was even
longer. Logically, this would make indices of electrical
remodeling less good predictors of SR maintenance[40].
The ratio of DACL and left atrial size was the only signifi-
cant predictor in our primary analysis for the maintenance
of sinus rhythm six weeks after DC-cardioversion. In the
study of Bollmann et al the predictive properties of atrial
fibrillatory rate were improved by mathematically deriv-
ing an arbitrary formula including systolic left atrial size.
We were unable to validate this formula. To the best of our
knowledge, this is the first report, which has combined
electrophysiological and anatomical atrial variables, as a
pre-specified entity, in a study of outcome following car-
dioversion. These results are interesting as they assess dif-
ferent aspects of atrial disease, electrical remodeling and
dilatation, respectively. However, if these measurements
also have any predictive value in regard of more long-term
result remains to be evaluated.
Study limitations
A limitation of our study was that refractory period is esti-
mated indirectly from the dominating atrial cycle length
during AF. The method does not allow discrimination of
the refractory period from conduction velocity. Thus, the
DACL can only be used as an index of the refractory
period. Moreover, being an average over time, DACL does
not take rapid fluctuations in electrical electrophysiology
into account (i.e. rate adaptive response)[41,42]. Utilisa-
tion of calcium channel antagonists was not controlled or
randomised as it was not known at the time of study
design that these agents may reduce early arrhythmia
recurrence[7].
Atrial size is assessed by measuring the parasternal ante-
rior-posterior dimension of the left atrium rather than
determining atrial area or volume. Failure of the atrial
diameter to predict AF recurrence could be due to small
sample size. Therefore it remains unclear which measure-
ment of atrial size that best reflects the propensity of the
arrhythmia to recur. While this may be hypothetical draw-
back, a recent study found no benefit of left atrial volume
over anterior-posterior diameter in predicting the out-
come of cardioversion[43].
Table 2: Measured parameters
SR AF p-value
Clinical
Male 9/10 13/22 0.11*
Age (years) 70 (5) 68 (7) 0.41
Weight (kg) 82 (9) 86 (13) 0.69
BMI (kg/m2) 27 (3) 29 (5) 0.23
AF Duration (months) 4 (2) 6 (2) 0.13
Lone AF 7/10 16/22 1.00*
Anatomic
Ejection Fraction (%) 54 (2) 49 (10) 0.14
LA Diameter (mm) 44 (7) 48 (4) 0.08
Electrophysiologic
DACL V1 155 (17) 152 (15) 0.69
DACL Oes 151 (18) 147 (14) 0.59
Shortest DACL 148 (18) 145 (13) 0.59
Pre-specified combined parameters
DACL V1/LA 3.6 (0.4) 3.2 (0.5) 0.05
DACL Oes/LA 3.5 (0.6) 3.1 (0.4) 0.05
Shortest DACL/LA 3.4 (0.6) 3.1 (0.4) 0.04
Discriminatory power of tested parameters. These are listed grouped according to their demographic, anatomical or electrical nature. Some 
combined parameters were pre-specified and these are listed separate from other additional parameters. Key: BMI = body mass index; LA = left 
atrial diameter; DACL = dominating atrial cycle length; V1 = V1 lead; Oes = oesophageal lead; SR = sinus rhythm; AF = atrial fibrillation. Fischer 
exact test used to calculate p-values marked '*'. MannWhitney test used for all others.BMC Cardiovascular Disorders 2006, 6:11 http://www.biomedcentral.com/1471-2261/6/11
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Conclusion
This study demonstrates that combining electrophysio-
logical and anatomical measurements only slightly
improves the prediction of maintenance of sinus rhythm
following DC-cardioversion of AF. However, the ability to
identify those who will relapse using an index of the
refractory period during AF failed, underlining that other
ways to asses electrical remodeling and / or other variables
besides electrical remodeling should be considered in
determining the outcome following cardioversion. Docu-
mented additional triggers and promoters of AF include
ectopic atrial foci[44], interatrial impulse block[45] and
premature atrial impulses[46]. Identification and quanti-
fication of these may be required to improve risk stratifi-
cation for arrhythmia recurrence.
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